MA37841A1 - Immunoconjugués comprenant des anticorps anti-cd79b - Google Patents

Immunoconjugués comprenant des anticorps anti-cd79b

Info

Publication number
MA37841A1
MA37841A1 MA37841A MA37841A MA37841A1 MA 37841 A1 MA37841 A1 MA 37841A1 MA 37841 A MA37841 A MA 37841A MA 37841 A MA37841 A MA 37841A MA 37841 A1 MA37841 A1 MA 37841A1
Authority
MA
Morocco
Prior art keywords
immunoconjugates
cd79b antibodies
cd79b
antibodies
methods
Prior art date
Application number
MA37841A
Other languages
English (en)
Inventor
Paul Polakis
Andrew Polson
Susan Diane Spencer
Shang-Fan Yu
Bing Zheng
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2013/049519 external-priority patent/WO2014011521A1/fr
Publication of MA37841A1 publication Critical patent/MA37841A1/fr

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des immunoconjugués comprenant des anticorps anti-cd79b liés par covalence à un dérivé de némorubicine et des méthodes d'utilisation de ceux-ci.
MA37841A 2012-07-09 2013-07-08 Immunoconjugués comprenant des anticorps anti-cd79b MA37841A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261669268P 2012-07-09 2012-07-09
PCT/US2013/049519 WO2014011521A1 (fr) 2012-07-09 2013-07-08 Immunoconjugués comprenant des anticorps anti-cd79b

Publications (1)

Publication Number Publication Date
MA37841A1 true MA37841A1 (fr) 2018-06-29

Family

ID=63586954

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37841A MA37841A1 (fr) 2012-07-09 2013-07-08 Immunoconjugués comprenant des anticorps anti-cd79b

Country Status (1)

Country Link
MA (1) MA37841A1 (fr)

Similar Documents

Publication Publication Date Title
MA37840A3 (fr) Immunoconjugués comprenant des anticorps anti-cd79b
MA40671A1 (fr) Anticorps anti-c10orf54 et leurs utilisations
PH12014502826A1 (en) Immunoconjugates comprising anti-cd79b antibodies
MA37538A2 (fr) Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation
EA201590174A1 (ru) Иммуноконъюгаты, содержащие анти-cd22 антитела
PH12014502825A1 (en) Immunoconjugates comprising anti-cd22 antibodies
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
MA46820A (fr) Composition pharmaceutique comprenant des constructions d'anticorps bi-spécifiques
MA43187A (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
MA40938A (fr) Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps
MA41937A (fr) Conjugués de médicaments comprenant des anticorps contre la claudine 18.2
MA35712B1 (fr) Anticorps anti-htra1 et leurs procédés d'utilisation
EA201401254A1 (ru) Самостабилизирующиеся линкерные конъюгаты
UY34698A (es) Combinaciones farmacéuticas que comprenden un análogo de tionucleótidos
MA35898B1 (fr) Anticorps anti-lrp5 et leurs procédés d'utilisation
BR112014031310A2 (pt) anticorpos anti-pcsk9, formulações, dosagem e métodos de uso
MA35009B1 (fr) Cristaux d'anticorps anti-sclérotine et formulations de ceux-ci
BR112015000329A2 (pt) formulações de diclofenac
MA43345A (fr) Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
BR112014005935A2 (pt) derivados de anilina, sua preparação e sua aplicação terapêutica
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
BR112016010051A2 (pt) ?conjugados de anticorpo-fármaco anti-efna4?
MA37841A1 (fr) Immunoconjugués comprenant des anticorps anti-cd79b
MA37839A1 (fr) Immunoconjugués comprenant des anticorps anti-cd22